Physician Wealth Advisors Inc. Makes New $56,000 Investment in Marsh & McLennan Companies, Inc. (NYSE:MMC)

Physician Wealth Advisors Inc. bought a new position in Marsh & McLennan Companies, Inc. (NYSE:MMCFree Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 264 shares of the financial services provider’s stock, valued at approximately $56,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of MMC. Norges Bank acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at approximately $1,236,186,000. Amundi increased its stake in shares of Marsh & McLennan Companies by 81.1% in the 4th quarter. Amundi now owns 4,072,976 shares of the financial services provider’s stock valued at $860,824,000 after buying an additional 1,823,807 shares during the period. Assenagon Asset Management S.A. raised its position in shares of Marsh & McLennan Companies by 7,320.9% during the fourth quarter. Assenagon Asset Management S.A. now owns 1,108,758 shares of the financial services provider’s stock worth $235,511,000 after acquiring an additional 1,093,817 shares during the last quarter. Raymond James Financial Inc. bought a new position in Marsh & McLennan Companies in the fourth quarter valued at about $207,278,000. Finally, Proficio Capital Partners LLC increased its position in Marsh & McLennan Companies by 29,648.6% in the fourth quarter. Proficio Capital Partners LLC now owns 688,978 shares of the financial services provider’s stock worth $146,346,000 after purchasing an additional 686,662 shares during the period. Institutional investors and hedge funds own 87.99% of the company’s stock.

Wall Street Analysts Forecast Growth

MMC has been the topic of several analyst reports. JPMorgan Chase & Co. increased their price objective on shares of Marsh & McLennan Companies from $230.00 to $235.00 and gave the company a “neutral” rating in a report on Friday, January 3rd. Raymond James reissued an “outperform” rating and issued a $250.00 price target (up previously from $240.00) on shares of Marsh & McLennan Companies in a research note on Thursday, February 6th. Royal Bank of Canada upgraded Marsh & McLennan Companies from a “sector perform” rating to an “outperform” rating and upped their price objective for the company from $242.00 to $250.00 in a report on Thursday, December 12th. Redburn Atlantic initiated coverage on Marsh & McLennan Companies in a report on Tuesday, March 25th. They set a “buy” rating and a $281.00 target price on the stock. Finally, Wells Fargo & Company upped their price target on Marsh & McLennan Companies from $212.00 to $223.00 and gave the company an “equal weight” rating in a research note on Friday, January 31st. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $233.41.

Check Out Our Latest Analysis on Marsh & McLennan Companies

Insider Activity at Marsh & McLennan Companies

In other Marsh & McLennan Companies news, VP Stacy Mills sold 1,317 shares of the firm’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $234.97, for a total value of $309,455.49. Following the completion of the transaction, the vice president now directly owns 2,923 shares in the company, valued at $686,817.31. This trade represents a 31.06 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Nicholas Mark Studer sold 49,390 shares of the firm’s stock in a transaction on Wednesday, March 12th. The shares were sold at an average price of $230.16, for a total transaction of $11,367,602.40. Following the completion of the transaction, the chief executive officer now directly owns 28,329 shares of the company’s stock, valued at $6,520,202.64. This represents a 63.55 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 57,828 shares of company stock valued at $13,350,279. Corporate insiders own 0.30% of the company’s stock.

Marsh & McLennan Companies Price Performance

MMC stock opened at $243.95 on Tuesday. The stock has a 50-day moving average price of $230.22 and a two-hundred day moving average price of $224.18. Marsh & McLennan Companies, Inc. has a 1 year low of $196.17 and a 1 year high of $245.98. The stock has a market cap of $119.81 billion, a PE ratio of 29.79, a price-to-earnings-growth ratio of 2.70 and a beta of 0.95. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.44.

Marsh & McLennan Companies (NYSE:MMCGet Free Report) last posted its quarterly earnings data on Thursday, January 30th. The financial services provider reported $1.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.75 by $0.12. Marsh & McLennan Companies had a return on equity of 32.60% and a net margin of 16.60%. Equities analysts forecast that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current fiscal year.

Marsh & McLennan Companies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 3rd will be given a $0.815 dividend. This represents a $3.26 dividend on an annualized basis and a dividend yield of 1.34%. The ex-dividend date is Thursday, April 3rd. Marsh & McLennan Companies’s dividend payout ratio is presently 39.80%.

Marsh & McLennan Companies Company Profile

(Free Report)

Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.

Featured Articles

Want to see what other hedge funds are holding MMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MMCFree Report).

Institutional Ownership by Quarter for Marsh & McLennan Companies (NYSE:MMC)

Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.